Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Princeton National Bancorp Q4 Loss Plunges

Princeton National Bancorp, Inc. (PNBC: Quote), the parent corp. of Citizens First National Bank, reported a fourth-quarter net loss to common shareholders of $34.7 million or $10.39 per share, wider than the net loss of $16.1 million or $4.85 per share in the year-ago quarter.

Net interest income for the quarter declined to $8.2 million from $9.4 million in the same period last year. Net interest margin for the quarter fell to 3.87 percent from 4.16 percent last year.

Total non-interest income for the quarter slid to $2.9 million from $3.8 million the prior year.

Loan loss provision for the quarter increased to $33.9 million from $27.2 million in the year-ago quarter.

Click here to receive FREE breaking news email alerts for Princeton National Bancorp Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.